𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Serum levels of coenzyme Q10in patients with Alzheimer's disease

✍ Scribed by F. de Bustos; J. A. Molina; F. J. Jiménez-Jiménez; A. García-Redondo; C. Gómez-Escalonilla; J. Porta-Etessam; A. Berbel; M. Zurdo; B. Barcenilla; G. Parrilla; R. Enriquez-de-Salamanca; J. Arenas

Publisher
Springer
Year
2000
Tongue
English
Weight
75 KB
Volume
107
Category
Article
ISSN
1435-1463

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Assessment of coenzyme q10 tolerability
Assessment of coenzyme q10 tolerability in huntington's disease
✍ Dr. A. Feigin; K. Kieburtz; P. Como; C. Hickey; D. Abwender; C. Zimmerman; K. St 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 273 KB

## Abstract We performed a 6‐month open‐label trial to evaluate the tolerability and efficacy of coenzyme Q10 (CoQ) in 10 patients with Huntington's disease (HD), Subjects were evaluated at baseline, 3 months, and 6 months using the HD Rating Scale (HDRS), the HD Functional Capacity Scale (HDFCS),

Increased hair polyamine levels in patie
Increased hair polyamine levels in patients with alzheimer's disease
✍ Man Ho Choi; Kyoung-Rae Kim; In Seong Kim; Dong Seok Lho; Bong Chul Chung 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 108 KB 👁 2 views

Recently, the neurotoxic amyloid ␤-peptide was shown to up-regulate polyamine metabolism by increasing ornithine decarboxylase (ODC) activity and polyamine uptake by initiating free radical damage in Alzheimer's disease (AD). 1 Because of these findings, polyamines have been considered to play an im